OnKure Therapeutics (OKUR) Assets (2020 - 2026)
OnKure Therapeutics' (OKUR) quarterly Assets came in at $198.7 million in Q1 2026, up 98.93% YoY from $99.9 million in Q1 2025, and up 219.87% on a QoQ basis from $62.1 million in Q4 2025.
OnKure Therapeutics (OKUR) Assets (2020 - 2026) Analysis & Trends
OnKure Therapeutics (OKUR) has 7 years of Assets data on file, last reported at $198.7 million in Q1 2026.
- Quarterly Assets rose 98.93% year-over-year to $198.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $198.7 million (up 98.93% YoY) and the FY2025 annual result came in at $62.1 million, down 45.94% from the prior year.
- Assets grew to $198.7 million in Q1 2026, from $62.1 million in the prior quarter.
- In the past five years, Assets ranged from a high of $198.7 million in Q1 2026 to a low of $35.7 million in Q4 2023.
- A 5-year average of $105.7 million and a median of $99.9 million in 2025 frame the typical range for Assets.
- Annual changes were most pronounced in 2023 — Assets plunged 66.97% — and 2024, when it surged 221.56%.
- Tracing OKUR's Assets over 5 years: stood at $108.2 million in 2022, then sank by 66.97% to $35.7 million in 2023, then surged by 221.56% to $114.9 million in 2024, then sank by 45.94% to $62.1 million in 2025, then surged by 219.87% to $198.7 million in 2026.
- The last three Assets figures came in at $198.7 million (Q1 2026), $62.1 million (Q4 2025), and $72.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | OnKure Therapeutics | 196.98 Mn | 20.60 Mn | - | 179.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 179.35 Mn |
| Mar 31, 2026 | 198.69 Mn |
| Dec 31, 2025 | 62.12 Mn |
| Sep 30, 2025 | 72.84 Mn |
| Jun 30, 2025 | 86.07 Mn |
| Mar 31, 2025 | 99.88 Mn |
| Dec 31, 2024 | 114.91 Mn |
| Sep 30, 2024 | 77.65 Mn |
| Jun 30, 2024 | 78.72 Mn |
| Mar 31, 2024 | 84.64 Mn |
| Dec 31, 2023 | 35.73 Mn |
| Sep 30, 2023 | 130.39 Mn |
| Jun 30, 2023 | 148.04 Mn |
| Mar 31, 2023 | 98.87 Mn |
| Dec 31, 2022 | 108.18 Mn |
| Sep 30, 2022 | 122.50 Mn |
| Jun 30, 2022 | 133.61 Mn |
| Mar 31, 2022 | 144.41 Mn |
| Dec 31, 2021 | 154.02 Mn |
| Sep 30, 2021 | 162.94 Mn |